サンプル分類1
CJC-1295+IPA(CP10)
- 10mg*10vials (CJC-1295 5mg + IPA 5mg) USD 116.00
参考価格です。お支払いの前にコンシェルジュが金額を確認します。
4.9 / 5 · 2291 件注文の送信後、コンシェルジュへ連絡するときは注文番号をお知らせください。
製品の特長
Promote GH secretion, build muscle, and reduce fat
製品紹介
This formulation combines CJC-1295 (without DAC)—a modified growth hormone-releasing hormone (GHRH) analog—with Ipamorelin, a selective growth hormone secretagogue (GHS). CJC-1295 (without DAC) produces a sustained, dose-dependent increase in GH and IGF-1 levels, while Ipamorelin selectively stimulates GH release without increasing ACTH or cortisol.
注意事項
Reconstitution: Add 3.0 mL of sterile water → total concentration ~3.33 mg/mL (1.67 mg/mL for each peptide)
Typical daily dosage range: 100–300 mcg of each peptide, once daily
Easy measurement: 1 unit = 0.01 mL of each peptide ≈ 33.3 mcg
使い方
1. Use a sterile syringe to draw 3.0 mL of bacteriostatic water.
2. Inject slowly along the side of the vial; avoid creating bubbles.
3. Gently rotate/roll the vial until dissolved (do not shake).
4. Label and store refrigerated at 2–8°C, protected from light.
保存方法
Lyophilized: Store in a dry, dark place at -20°C.
After reconstitution: Store refrigerated at 2–8°C; use within ~28 days; avoid freeze-thaw cycles.
レビュー
4.9 / 5
2291 件
最新100件を表示しています。
-
★★★★★
VXC•••••••FF3A
カナダ
2026-10-26 18:42
The inner pack was tidy. The closure was clean. Simple and correct.
-
★★★★★
VX1•••••••0D9E
フランス
2026-10-26 14:49
The tracking page paused for a day. What I ordered was inside. The order was right.
-
★★★★★
VXF•••••••9765
フランス
2026-10-26 10:56
Support confirmed the destination before dispatch. Nothing was missing. Clear from start to finish.
-
★★★★★
VX2•••••••6D20
米国
2026-10-26 07:04
The parcel was packed securely. The storage note was easy to follow. I had no follow-up questions.
-
★★★★★
VX7•••••••A3DD
その他
2026-10-26 03:11
Delivery ran past the first window. The product matched the listing. A middling delivery, and a correct order.
-
★★★★★
VXB•••••••7E57
カナダ
2026-10-25 23:18
Everything listed was in the box. The batch note was readable. A reliable delivery.
-
★★★★★
VXF•••••••8B51
フランス
2026-10-25 19:26
Tracking matched the arrival. The vial matched the description. I would use this listing again.
-
★★★★★
VX0•••••••1FB1
カナダ
2026-10-25 15:33
The paperwork was easy to read. The storage note was easy to follow. A reliable delivery.
-
★★★★★
VXC•••••••3E3A
カナダ
2026-10-25 11:40
The box was plain and undamaged. The item was as described. Everything checked out.
-
★★★★★
VX1•••••••8C67
シンガポール
2026-10-25 07:47
The handover was smooth. The cap was tight. Pleased with how it was sent.
購入者レビュー
注文時の注文番号と電話番号を入力してください。この商品を含む注文と両方が一致する必要があります。
ほかの掲載商品
サンプル分類1
Cagrilintide
Cagrilintide is a long-acting, acylated amylin analogue—a pancreatic hormone—designed for once-weekly subcutaneous injection. It activates central amylin receptors, promoting satiety, slowing gastric emptying, and reducing food intake. In Phase 2 and Phase 3 clinical trials, cagrilintide induced dose-dependent weight loss, with side effects primarily being gastrointestinal in nature.
参考価格USD 113.00
サンプル分類1
Retatrutide
Retatrutide is an investigational triple-receptor agonist peptide (targeting GLP-1, GIP, and glucagon receptors) currently under development for the treatment of obesity and type 2 diabetes. Phase II clinical trials have demonstrated significant weight loss, with patients in the high-dose group achieving a weight reduction of up to 24% over 48 weeks. This educational program outlines a once-weekly subcutaneous administration regimen, incorporating a gradual dose-escalation approach to minimize gastrointestinal side effects.
参考価格USD 45.00
サンプル分類1
Tirzepatide
Tirzepatide is a dual incretin receptor agonist composed of 39 amino acids. It activates both GLP-1 and GIP receptors, thereby enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite. With a half-life of approximately 5 days, it is convenient to administer via a once-weekly subcutaneous injection. Clinical trials have demonstrated that tirzepatide offers superior efficacy in terms of glycemic control and weight loss compared to selective GLP-1 receptor agonists.
参考価格USD 40.00
サンプル分類1
Tesamorelin
Tesamorelin is a synthetic 44-amino acid peptide analog that resembles growth hormone-releasing hormone (GHRH). It stimulates the release of endogenous growth hormone and increases IGF-1 levels, thereby promoting lipolysis and providing metabolic benefits. Tesamorelin has been approved by the FDA for the reduction of visceral adipose tissue in individuals with HIV-associated lipodystrophy.
参考価格USD 41.00